28 results match your criteria: "Center for Pharmaceutical Research and Development[Affiliation]"
Bioorg Med Chem Lett
July 2001
Bristol-Myers Squibb, Pharmaceutical Research Institute, Richard L. Gelb Center for Pharmaceutical Research and Development, 5 Research Parkway, 06492, Wallingford, CT, USA.
New analogues of paclitaxel (1a, active constituent of Taxol) were synthesized containing an epoxide at the C-10 position. The introduction of the epoxide was carried out by selective removal of the C10-acetate followed by protection of the C2'- and C7-hydroxyl groups. After oxidation to yield a ketone at the C10-position, this intermediate was reacted with dimethylsulfonium ylide.
View Article and Find Full Text PDFCancer Chemother Pharmacol
June 1999
Bristol-Myers Squibb Pharmaceutical Research Institute, Richard L. Gelb Center for Pharmaceutical Research and Development, Wallingford, CT 06492-7660, USA.
The positive impact on survival of traditional chemotherapeutic agents has renewed interest in developing newer cytotoxic agents and orally active compounds with improved therapeutic indices. In addition, new insights into the pathways of human tumorigenesis have led to novel approaches aimed at specific mechanism-based targets. The taxane class, of which paclitaxel was the first member, has the unique ability to promote and stabilize microtubule function directly, thereby inhibiting mitotic progression and inducing apoptotic cell death.
View Article and Find Full Text PDFInt J Pept Protein Res
August 1996
Department of Central Nervous System Chemistry, Richard L. Gelb Center for Pharmaceutical Research and Development, Bristol-Myers Squibb, Wallingford, Connecticut, USA.
The synthesis and iodination of a structural analogue of the specific large-conductance calcium-activated potassium (BK) channel blocker, iberiotoxin (IbTX), a 37-amino acid scorpion neurotoxin, is reported. The synthesis of this analogue, [Tyr5, Phe36]-IbTX, was accomplished using standard solid-phase Fmoc (9-fluorenylmethoxycarbonyl) chemistry protocols. The linear peptide was cyclized via the formation of three intramolecular disulfide bridges and subsequently iodinated at the Tyr5 position.
View Article and Find Full Text PDF